Market overview
The dental market in the UK continues to be fragmented with 12,085 registered dental companies to only 14,340 dental practices in 2020.
Read moreMaximising opportunities
We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Our latest transactions
-
Clearwater Advisers
Adviser to Evergreen on raising strategic finance
-
Clearwater Advisers
Adviser to Gradiente on raising finance to support the acquisition of a majority stake in the share capital of Giuriati Group S.r.l.
View more -
Clearwater Advisers
Adviser to Veranex and Summit Partners on the acquisition of IMMR
View more -
Clearwater Advisers
Adviser to Alflow Scandinavia A/S on the sale to Indutrade AB
View more -
Clearwater Advisers
Adviser to Banook and Turenne Capital on the acquisition of Nabios
View more -
Clearwater Advisers
Adviser to Groupe Saint-Gatien on the sale of Théraé Centre Médical to Colisée
-
Clearwater Advisers
Adviser to Meet Recruitment on its MBO supported by NorthEdge Capital
View more -
Clearwater Advisers
Adviser to Dominique Dutscher on the acquisition of AH Diagnostics
View more -
Clearwater Advisers
Adviser to Laboratorios Ordesa on the acquisition of Laboratorios Sodeinn, S.L.
View more -
Clearwater Advisers
Adviser to shareholding management on the sale of a majority stake in Aegide Domitys to AG2R La Mondiale
-
Clearwater Advisers
Adviser to SRS on its reinvestment in DomusVi alongside ICG and Management
View more -
Clearwater Advisers
Adviser to Palatine Private Equity on its investment in Routes Healthcare
View more
Luc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
Our Healthcare Team
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 65
deals advised upon
in the last 5 years
€9.4bn
in deal value
over the last 5 years
Over 40%
deals involving PE
in the last 5 years
Insights
-
-
Pan-European consolidators
Whilst the UK healthcare market is unique in several ways, many of the same market dynamics present in the UK also exist in Europe.
Read more -
Notable M&A activity
There has been notable M&A activity in the dental market during the last year.
Read more
